Chordate Medical Financials
| CMH Stock | 18.05 0.80 4.24% |
Chordate |
Understanding current and past Chordate Medical Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Chordate Medical's financial statements are interrelated, with each one affecting the others. For example, an increase in Chordate Medical's assets may result in an increase in income on the income statement.
Please note, the imprecision that can be found in Chordate Medical's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Chordate Medical Holding. Check Chordate Medical's Beneish M Score to see the likelihood of Chordate Medical's management manipulating its earnings.
| Foreign Associate | USA |
| Instrument | Sweden Stock View All |
| Exchange | Stockholm Exchange |
| ISIN | SE0009495559 |
| Business Address | KistagAngen 20B, Kista, |
| Sector | Healthcare |
| Industry | Medical Devices |
| Benchmark | Dow Jones Industrial |
| Website | www.chordate.com |
| Phone | 46 8 40 01 15 86 |
You should never invest in Chordate Medical without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of Chordate Stock, because this is throwing your money away. Analyzing the key information contained in Chordate Medical's financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.
Chordate Medical Key Financial Ratios
Chordate Medical's financial ratios allow both analysts and investors to convert raw data from Chordate Medical's financial statements into concise, actionable information that can be used to evaluate the performance of Chordate Medical over time and compare it to other companies across industries.| Return On Equity | -1.68 | |||
| Return On Asset | -0.71 | |||
| Beta | 1.27 |
Chordate Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Chordate Medical's current stock value. Our valuation model uses many indicators to compare Chordate Medical value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Chordate Medical competition to find correlations between indicators driving Chordate Medical's intrinsic value. More Info.Chordate Medical Holding is rated below average in return on equity category among its peers. It also is rated below average in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Chordate Medical's earnings, one of the primary drivers of an investment's value.Chordate Medical Holding Systematic Risk
Chordate Medical's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Chordate Medical volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was ten with a total number of output elements of fifty-one. The Beta measures systematic risk based on how returns on Chordate Medical Holding correlated with the market. If Beta is less than 0 Chordate Medical generally moves in the opposite direction as compared to the market. If Chordate Medical Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Chordate Medical Holding is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Chordate Medical is generally in the same direction as the market. If Beta > 1 Chordate Medical moves generally in the same direction as, but more than the movement of the benchmark.
Chordate Medical Thematic Clasifications
Chordate Medical Holding is part of Drugs investing theme. If you are a theme-oriented, socially responsible, and at the same time, a result-driven investor, you can align your investing habits with your values without jeopardizing your expectations about returns. You can easily create an optimal portfolio of stocks, ETFs, funds, or cryptocurrencies based on a specific theme of your liking. Drug manufacturing and delivery. Companies involved in medical and pharmaceutical drug research, manufacturing, and delivery
This theme covers Drug manufacturing and delivery. Companies involved in medical and pharmaceutical drug research, manufacturing, and delivery. Get More Thematic Ideas
| Drugs | View |
Chordate Medical November 30, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Chordate Medical help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Chordate Medical Holding. We use our internally-developed statistical techniques to arrive at the intrinsic value of Chordate Medical Holding based on widely used predictive technical indicators. In general, we focus on analyzing Chordate Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Chordate Medical's daily price indicators and compare them against related drivers.
| Information Ratio | (0.07) | |||
| Maximum Drawdown | 30.07 | |||
| Value At Risk | (6.97) | |||
| Potential Upside | 12.85 |
Additional Tools for Chordate Stock Analysis
When running Chordate Medical's price analysis, check to measure Chordate Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Chordate Medical is operating at the current time. Most of Chordate Medical's value examination focuses on studying past and present price action to predict the probability of Chordate Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Chordate Medical's price. Additionally, you may evaluate how the addition of Chordate Medical to your portfolios can decrease your overall portfolio volatility.